Brief: Immunovia Inc Receives Approval To Begin Testing Patients For Pancreatic Cancer With IMMray PanCan-d Test
04/08/2021 12:59
Aug 4 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA, INC. RECEIVES APPROVAL TO BEGIN TESTING
PATIENTS FOR
PANCREATIC CANCER WITH THE IMMRAY™ PANCAN-D TEST
Source text for Eikon: ID:nPre9X1N2a
Further company coverage: IMMNOV.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study